Among these were EGFR accessibility in ccRCC, TOP1 expression in UCEC, MM and ccRCC, and FGFR2 expression in GBM, ccRCC and basal BRCA. This evidence concerns the gene EGFR and nonpapillary renal cell carcinoma.